Peloton posted its first full-year net profit of $63.2 million in fiscal 2026, driven by price increases, but shares tumbled nearly 13% as the company forecast lower sales for fiscal 2027.
Broadcom's stock dropped sharply after its fiscal Q2 revenue missed market expectations and it did not raise its annual AI chip sales forecast. Despite beating EPS estimates, the software division's performance and unchanged AI guidance led to a significant decline in its share price.
Eli Lilly reported first-quarter revenue of $19.80 billion, up 56% year-over-year, beating analyst expectations of $17.62 billion. Adjusted EPS was $8.55 vs $6.66 expected. The pharmaceutical giant raised its 2026 full-year revenue guidance to $82-85 billion, up $2 billion from prior outlook, driven by surging demand for Zepbound ($4.16B, +80% YoY) and Mounjaro ($8.66B, +125% YoY). Net income jumped to $7.40 billion from $2.76 billion a year ago.
